This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Murine Subrenal Capsule Assay

Kenneth J. McCormick, PhD; William R. Panje, MD; Sharon Seltzer, MD; Roger H. Merrick, BSMT

Arch Otolaryngol. 1983;109(11):715-718.

Abstract
• The murine subrenal capsule assay was used to determine chemotherapeutic sensitivities of metastatic, primary, or recurrent head and neck cancers. Tumor fragments (1 cu mm) were implanted under the renal capsule of 2- to 4-month-old normal female C57 BL/6 X DBA/2 F, hybrid mice. Xenografts included 20 squamous cell carcinomas (SCCs), one mucoepidermoid carcinoma, one adenoid cystic carcinoma, and two melanomas. Groups of tumor-bearing mice were treated with chemotherapy daily for five days. Sensitivities of the tumor were assessed on day 6 by comparison of final implant size with initial implant size. Significant oncolytic activity was detected against 16 of 24 tumors (14 of 20 SCCs and both melanomas). Correlations between the in vivo assay and clinical studies are needed to determine its predictive value.

(Arch Otolaryngol 1983;109:715-718)

Author Affiliations
From the Division of Head and Neck Surgical Oncology, Department of Otolaryngology—Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City.

Footnotes
Accepted for publication April 18, 1983.

Read before the American Society for Head and Neck Surgery, Palm Springs, Calif, March 11, 1983.

Reprint requests to Department of Otolaryngology—Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA 52242 (Dr McCormick).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?